Patent US4264602A successfully refreshed from Google Patents.
← Back to Patent Explorer
US4264602A Expired / Lapsed US ⏱️ 0.0 years remaining

4-Hydroxy-3-nitro-pyrido[2,3-B]pyridine-2(1H)-ones

Assignee: Sandoz Inc
•
Filing: 1976-07-21
•
Granted: 1981-04-28
•
Expires: 1996-07-21
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract Anti-allergic 4-hydroxy-3-nitro-pyrido[2,3-b]pyridines-2(1H)-ones are prepared by reacting a 3,4-dihydro-1,3-dioxo-1H-pyrido[2,3-d][1,3]oxazine (a 3-azaisatoic anhydride) with the carbanion resulting from the reaction of nitro acetic acid alkyl esters with a proton abstracting agent.

Inventors

  • 👤 Goetz E. Hardtmann

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-11-09 19:41
CPC Classifications
C; C07; C07D; C07D471/00; C07D471/02; C07D471/04

Claims Analysis

Total Claims: 11
Claim 1
Independent Claim 33 words
A compound of the formula: ##STR6## wherein R o is alkyl of 1 to 6 carbon atoms or allyl, M is hydrogen or a pharmaceutically acceptable cation, and R' is hydrogen or methyl.
Claim 2
Dependent Claim 33 words
A compound of the formula: ##STR6## wherein R o is alkyl of 1 to 6 carbon atoms or allyl, M is hydrogen or a pharmaceutically acceptable cation, and R' is hydrogen or methyl.
Claim 3
Dependent Claim 10 words
A compound of claim 1 in which M is hydrogen.
Claim 4
Dependent Claim 10 words
A compound of claim 1 in which R' is hydrogen.
Claim 5
Dependent Claim 8 words
The compound of claim 1 which is 1,7-dimethyl-4-hydroxy-3-nitro-pyrido[2,3-b]pyridine-2(1H)-one.
Claim 6
Dependent Claim 8 words
The compound of claim 1 which is 1-allyl-7-methyl-4-hydroxy-3-nitro-pyrido[2,3-b]pyridine-2(1H)-one.
Claim 7
Dependent Claim 22 words
A pharmaceutical composition comprising an inert pharmaceutically acceptable carrier and a symptomatic allergy treating effective amount of a compound of claim 1.
Claim 8
Dependent Claim 32 words
The method of symptomatically treating allergic conditions due to histamine release comprising administering to a mammal in need of such treatment an allergy treating effective amount of a compound of claim 1.
Claim 9
Dependent Claim 10 words
The method of claim 7 in which R' is hydrogen.
Claim 10
Dependent Claim 11 words
The method of claim 7 in which the compound is 1,7-dimethyl-4-hydroxy-3-nitro-pyrido[2,3-b]pyridine-2(1H)-one.
Claim 11
Dependent Claim 11 words
The method of claim 7 in which the compound is 1-allyl-7-methyl-4-hydroxy-3-nitro-pyrido[2,3-b]pyridine-2(1H)-one.

References Cited (Backward Citations)

US3864493A Cited
US3885038A Cited
US3883653A Cited
US3879544A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1984-04-27 1984-10-27 1985-04-28 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1988-04-27 1988-10-27 1989-04-28 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 1992-04-27 1992-10-27 1993-04-28 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag